Imagine discovering that nearly £50 million of your hard-earned tax money has been spent on a single outsourced firm—a cost eight times higher than initially estimated. This is the shocking reality uncovered by the BBC regarding the NHS’s contract with Crawford & Company Adjusters, tasked with assessing claims of medical harm caused by Covid vaccines. But here’s where it gets even more startling: this staggering sum is nearly £20 million more than the total compensation awarded so far to those injured or bereaved by the vaccines.
Crawford’s five-year contract, originally valued at £6 million, still has over a year left to run, but a new company is set to take over in the coming months. So, what went wrong? According to an NHS spokesperson, the cost overrun is due to the volume of claims “exceeding anticipated levels.” To date, over 22,000 claims related to Covid vaccines have been filed, with the majority linked to AstraZeneca’s jab. Yet, only about 1% of these claims have resulted in compensation payouts, raising questions about the efficiency and fairness of the process.
These claims are managed under the UK-wide Vaccine Damage Payment Scheme (VDPS), for which Crawford has conducted medical assessments since March 2022. But here’s where it gets controversial: one law professor described the Crawford contract as “peculiar,” suggesting that given the “significant uncertainty” at the time, a shorter contract with a cap on claims would have been more prudent.
When asked why costs were allowed to spiral unchecked for so long, the NHS cited the “complex” nature of the contract and the varying timelines for public sector procurement. Crawford, whose parent company is based in the US, declined to comment directly, referring inquiries back to the NHS.
And this is the part most people miss: while the focus has been on the financial cost, the human impact of these claims—both for those seeking compensation and those administering the scheme—remains largely unexplored. Is this a case of unforeseen circumstances, or could better planning have prevented such a massive overspend?
What do you think? Was the NHS justified in allowing costs to escalate, or should there have been stricter controls in place? Share your thoughts in the comments—this is a conversation that deserves to be heard.
